Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K McClellan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Drugs in R&D|November 24, 1999
Cytokine-target therapies cost effective in Crohn's disease?K McClellan
British Journal of Addiction|July 1, 1991
Broadening the base of treatment for alcohol problems: a report which deserves to be debated. Will this vision be implemented?K McClellan
Journal of Psychoactive Drugs|October 1, 1984
Work-based drug programsK McClellan
Australian Family Physician|April 8, 1998
Sudden loss of visionK McClellan
Paediatric Drugs|May 17, 2001
Topiramate: a review of its use in childhood epilepsyD Ormrod, K McClellan
Drugs|June 12, 2001
DesloratadineK McClellan, B Jarvis
The British Journal of Ophthalmology|May 29, 2003
Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemiaB Golchin, K McClellan
Australian and New Zealand Journal of Ophthalmology|June 24, 1999
Squamous cell carcinoma with necrotizing scleritisN Younan, K McClellan
Drugs & Aging|February 24, 2001
Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucomaD Ormrod, K McClellan
Drugs|March 29, 2001
Oseltamivir: a review of its use in influenzaK McClellan, C M Perry
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Drugs in R&D|November 24, 1999
Cytokine-target therapies cost effective in Crohn's disease?K McClellan
British Journal of Addiction|July 1, 1991
Broadening the base of treatment for alcohol problems: a report which deserves to be debated. Will this vision be implemented?K McClellan
Journal of Psychoactive Drugs|October 1, 1984
Work-based drug programsK McClellan
Australian Family Physician|April 8, 1998
Sudden loss of visionK McClellan
Paediatric Drugs|May 17, 2001
Topiramate: a review of its use in childhood epilepsyD Ormrod, K McClellan
Drugs|June 12, 2001
DesloratadineK McClellan, B Jarvis
The British Journal of Ophthalmology|May 29, 2003
Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemiaB Golchin, K McClellan
Australian and New Zealand Journal of Ophthalmology|June 24, 1999
Squamous cell carcinoma with necrotizing scleritisN Younan, K McClellan
Drugs & Aging|February 24, 2001
Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucomaD Ormrod, K McClellan
Drugs|March 29, 2001
Oseltamivir: a review of its use in influenzaK McClellan, C M Perry
Pageof 4